drugset
drugset / Trial / NCT01978912

A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

NCT01978912 ↗

Phase 1/2 Completed 24 enrolled Teijin America, Inc.
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and exploratory efficacy of KTP-001 in subjects with lumbar disc herniation.

Timeline

Start
2013-02
Primary completion
2018-10-16
Completion
2018-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject KTP-001 Unknown 5 ug Other
Subject KTP-001 Unknown 15 ug Other
Subject KTP-001 Unknown 50 ug Other
Subject KTP-001 Unknown 150 ug Other

Indications

lumbar disk disease